The latest report from the international ImmuneScore project showed that the ImmuneScore, which is derived from a digital immunohistochemistry measure of CD3+ and CD8+ lymphocytes in the tumor core and invasive margin, is a reliable prognostic biomarker in colon cancer 8. The gene discussed is CD8A; the disease is neoplasm.